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doi:10.1016/j.ejvs.2009.06.003Abstract Background: The lower extremity is increasingly used as an access site in end-stage
renal diseasepatients.However, reports present conflicting results, creating confusion regarding
the feasibility and outcomes. Our objective is to review the available literature and analyse the
patency rates and complications of various types of lower-extremity arteriovenous access.
Methods: An Internet-based literature search was performed using MEDLINE to identify all
published reports on lower-extremity vascular access. The analysis involved studies comprising
at least 10 arteriovenous accesses with both inflow and outflow vessels in the lower extremity,
and reporting on patency rates and access-related complications. The weighted mean patency
rates were calculated, and the chi-square (c2) test was used to evaluate the differences in the
complication rates in the subgroups of patients identified.
Results: Three main types of lower-extremity vascular access were identified: the upper thigh
prosthetic, the mid-thigh prosthetic and the femoral vein transposition arteriovenous access.
There are limited data on saphenous vein loop grafts, which report poor results. The weighted
mean primary patency rates at 12 months were 48%, 43% and 83%, respectively. The weighted
mean secondary patency rates at 12 months were 69%, 67% and 93%, respectively. Access loss
as a result of infection was more common in upper thigh and mid-thigh grafts than femoral vein
transposition arteriovenous access (18.40%, 18.33% vs. 1.61%; P< 0.05). Ischaemic complications
rateswere higher in autologous than prosthetic arteriovenous access (20.97% vs. 7.18%,P< 0.05).
Conclusions: Lower-extremity vascular access has acceptable results in terms of patency, with
femoral vein transposition having better patency rates than femoral grafts. Autologous access
is associated with less infective complications, however, at the expense of increased ischaemic
complications rates. Further research with randomised trials is required to assess the outcomes
of lower-extremity vascular access.
ª 2009 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.ou, Souniou 11, 19001 Keratea, Greece.
yahoo.gr (G.A. Antoniou).
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366 G.A. Antoniou et al.Permanent vascular access for haemodialysis is a key issue arteriovenous haemodialysis accesses.
2 Secondary outcomein the management of patients with chronic renal failure.
Undoubtedly, the radial arteryecephalic vein arteriovenous
fistula is the first procedure of choice for the incident end-
stage renal disease patient, followed by secondary vascular
accesses, such as proximal native fistulae or arteriovenous
grafts in the upper extremities.1 However, in the light of
the ever increasing number of patients with end-stage renal
disease, the ageing dialysis population and their prolonged
longevity, surgeons are increasingly encountered with
difficult access problems, such as exhausted upper
extremity access sites and central venous outflow
obstruction resulting from previous catheterisation. The
constant evolution of angioaccess techniques in the pres-
ence of such circumstances has led to the development of
arteriovenous access at different anatomic sites, such as
the lower extremity. Femoral prosthetic arteriovenous
access placed either in the upper thigh or in the mid-thigh
in a loop configuration, as well as autogenous arteriovenous
access using the transposed superficial femoral vein, have
evolved as alternative access procedures in patients with
difficult access problems. However, contradictory results in
terms of outcome and complications, such as infection and
steal syndrome, have been reported in the existing
literature.
The purpose of this article was to systematically review
and analyse the available literature regarding the surgical
technique, patency rates and specific adverse events
complicating lower-extremity vascular access, based on
evidence derived from relevant studies.Methods
Data sources and study selection. An Internet-based liter-
ature search was performed using the MEDLINE and SCOPUS
electronic databases between January 1980 and January
2009. The literature search was confined to studies pub-
lished in English. The keywords ‘haemodialysis access’,
‘angioaccess’, ‘arteriovenous fistula’, ‘arteriovenous shunt
surgical’, and ‘lower extremity’, ‘femoral’ in all possible
combinations were used to identify relevant abstracts. If
there was any suggestion of the data looked for, the full
texts of relevant articles were retrieved for further
in-depth review. A second-level search included manual
search of the reference lists of the retrieved articles. The
literature search, study selection and data extraction were
performed by two independent authors (GAA, MKL).
Studies were included in this review if the following
criteria were fulfilled: (1) the study documented on the
construction of either autologous or prosthetic arteriove-
nous haemodialysis access with both outflow and inflow
vessels in the lower extremity, (2) the study comprised
a series of at least 10 arteriovenous accesses placed in the
lower extremity and (3) the study documented on the primary
and/or secondary patency rates by using either life table or
the KaplaneMeier method, included the patients at risk and
reported access-related complications.
Outcome measures and data abstraction. The primary
outcome measures were primary and secondary patency
rates, which were determined according to the reporting
standards, set by the Committee of Reporting Standards formeasures were special adverse events complicating lower-
extremity haemodialysis access. The severity of arteriove-
nous access complications was graded according to the
Reporting Standards document.2
Data abstracted (where available) from the individual
studies were: study design, access configuration, number of
patients and arteriovenous accesses created, patient
demographic data, primary/secondary patency rates,
access-related infection rate, grade of infection, access-
related ischaemic complication and amputation rate, and
other access-related complications. Data extraction was
performed from the text, tables or graphs of the relevant
studies.
Statistical analysis. Data retrieved from each relevant
paper were entered into a purpose-designed database using
SPSS 15 for Windows (SPSS Inc., Chicago, IL, USA). Data
were aggregated and presented as means with ranges. The
mean primary and secondary patency rates were averaged,
weighting the data of each study by the number of arte-
riovenous access created. The mean patency values were
calculated for 12 and 24 months following access
construction. Values were calculated for these time
periods, only if there were at least two studies to report for
this time period. The chi-square (c2) test was used to
evaluate the differences in the complication rates in the
subgroups of patients identified. All statistical tests were
two tailed, and a P value <0.05 was considered statistically
significant. The relationship between the access configu-
ration and complications was assessed using the odds ratio
(ORs) and 95% confidence intervals (CI).
Results
Literature search results
The systematic review of the literature identified 32 papers
with reference to outcome of lower-extremity vascular
access. Seventeen articles were excluded from further
analysis because either the inflow or outflow vessels were
outside the lower extremity (the so-called exotic vascular
procedures), they did not fulfill the preset criteria in terms
of the size of the study series, or because of inadequate
reported data.3e19 Fifteen studies were entered into the
final analysis, from which reliable data regarding primary
and/or secondary patency rates and complications could be
retrieved (Table 1).20e34 The year of publication ranged
from 1988 to 2006, with 67% of the studies published after
2000. Of these 15 studies, two were prospective, 10
retrospective, whereas the type of study was not reported
in three papers. No randomised controlled trials comparing
lower-extremity vascular access with that of upper
extremity or the various configurations of lower-extremity
vascular access (e.g., autologous and prosthetic) were
identified.
Surgical technique of formation of lower
extremity vascular access
Broadly divided, two types of lower-extremity vascular
access were identified: the autologous and the prosthetic
Table 1 Study description and outcome
Author Year Type of study Access configuration Number of
patients
Number of
accesses
Age
Englesbe et al.20 2006 Retrospective Upper thigh prosthetic
AV access
30 30 48 (mean)
Scott et al.21 2006 Retrospective Mid-thigh prosthetic AV access 38 46 57 (mean)
Cull et al.22 2004 Retrospective Upper thigh prosthetic
AV access
91 116 58 (median)
Hazinedarog˘lu et al.23 2004 Prospective Upper thigh prosthetic
AV access
15 17 61 (mean)
Femoral vein transposition 15 15 56 (mean)
Gradman et al.24 2004 NR Femoral vein transposition 22 22 48 (mean)
Miller et al.25 2003 Prospective Upper thigh prosthetic
AV access
NR 63 NR
Flarup et al.26 2003 NR Mid-thigh prosthetic AV access 11 14 56 (median)
Tashjian et al.27 2002 Retrospective Upper thigh prosthetic
AV access
73 73 62 (mean)
Gradman et al.28 2001 Retrospective Femoral vein transposition 25 25a 55 (mean)
Vogel et al.29 2000 Retrospective Upper thigh prosthetic
AV access
134 134b 56 (mean)
Korzets et al.30 1998 Retrospective Upper thigh prosthetic
AV access
35 37 55 (mean)
Khadra et al.31 1996 Retrospective Upper thigh prosthetic
AV access
61 74 50 (mean)
Taylor et al.32 1996 Retrospective Upper thigh prosthetic
AV access
39 45c 58 (mean)
Bhandari et al.33 1995 Retrospective Upper thigh prosthetic
AV access
46 49 49 (mean)
Slater et al.34 1988 NR Upper thigh prosthetic
AV access
21 22 50 (mean)
Males
(%)
Diabetes
(%)
Obesity
(%)
Primary patency Secondary patency Grade 2
infection
rate (%)
Ischaemic
complication
rate (%)
Amputation
rate (%)
43 33 50d NR 41 (12m)/26 (24m) 27 3f 7
42 36 NR 40 (12m)/18 (24m) 68 (12m)/43 (24m) 21 13 NR
37 44 27e 34 (12m)/19 (24m) 68 (12m)/54 (24m) 41 11 9
27 0 NR 38 (12m)/25 (24m) NR 24 18 0
13 0 NR 87 (12m) NR 7 33 0
55 32 NR 93 (12m)/85 (24m) 100 (12m)/94 (24m) 0 0 0
43 31 NR NR 62 (12m)/39 (24m) 11 0 0
55 9 NR 54 (12m)/18 (24m) 64 (12m)/18 (24m) 7 0 0
44 NR NR 71 (12m)/63 (24m) 83 (12m)/83 (24m) NS 1 1
28 60 56e 73 (12m) 86 (12m) 0 32 4
60 19 NR NR 62 (12m) 10 NR NR
40 23 NR NR 73 (12m)/65 (24m) 3 11 3
34 NR NR NR 77 (12m)/62 (24m) 14 3 1
41 NR NR 52 (12m)/47 (24m) NR 11 16 7
52 NR NR NR 85 (12m)/82 (24m) NS NR NR
NR NR NR NR 81 (24m) 9 NR NR
NR, not reported; NS, not specified; m, months.
a 7 composite prosthetic-transposed SFV fistulae.
b 126 loop, 8 cross-femoral.
c 39 PTFE, 6 bovine.
d BMI> 40.
e BMI> 30.
f Perioperative only.
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368 G.A. Antoniou et al.arteriovenous fistulae. The latter may be further sub-
divided into two types according to the site of the pros-
thetic graft. In the upper thigh prosthetic arteriovenous
access, a polytetrafluoroethylene (PTFE) graft is interposed
between the common femoral or superficial femoral artery
and the common femoral, superficial femoral or long
saphenous vein, and is placed in a loop configuration in the
subcutaneous plane of the anterior aspect of the thigh.31 A
modification of this technique is placement of the graft
along a subcutaneous loop channel over the anterior
mid-thigh region just proximal to the patella, and anasto-
mosing it to the superficial femoral artery and vein just
proximal to the adductor canal.14 Suprapubic cross-over
femoro-femoral arteriovenous graft to the contralateral
femoral vein has also been described.29 The autogenous
lower-extremity arteriovenous fistula is based on the
construction of the transposed superficial femoral/popli-
teal vein in a similar configuration to the transposed basilic
vein; the vein is mobilised from the knee joint to its junc-
tion to the common femoral vein, divided distally and
anastomosed to the superficial femoral artery just proximal
to the adductor hiatus, after having been placed in
a subcutaneous tunnel over the anterior thigh, lateral to
the skin incision.13 Construction of a loop-composite PTFE-
transposed superficial femoral vein has also been used
when the aforementioned configuration is not feasible.28
Furthermore, another type of autogenous lower extremity
arteriovenous fistula is the saphenous vein loop arteriove-
nous fistula. In this form of vascular access, the greater
saphenous vein is mobilised, ligated distally (usually at the
level of the knee joint), placed in a loop subcutaneous
tunnel over the anterior aspect of the thigh and anasto-
mosed to the common femoral artery.16 Of our selected
papers for further analysis, 11 studies examined patients
having undergone upper thigh prosthetic arteriovenous
access,20,22,23,25,27,29e34 two studies reported on mid-thigh
loop arteriovenous grafts21,26 and another three papers
documented their experience with transposed superficial
femoral vein.24,23,28 Articles reporting on the saphenous
vein loop fistula included limited numbers of accesses with
inadequate data and, therefore, could not be entered in
the analysis.16e19 One paper prospectively evaluated upper
thigh arteriovenous graft versus transposed superficial
femoral vein.23Outcome-patency rates
The total number of arteriovenous accesses created in the
lower extremity was 782; of these, 660 were upper-thigh
arteriovenous grafts, 60 were mid-thigh grafts and 62 were
femoral vein transposition arteriovenous fistulae. The
patients’ demographic characteristics are shown in Table 1.
It is evident that many of the studies failed to provide
adequate data regarding patient demographics.
For all types of lower-extremity arteriovenous access,
the primary patency rates at 12 months ranged between
34% and 93%, with a weighted mean of 53%; the primary
patency rates at 24 months ranged between 18% and 85%,
with a weighted mean of 37%. Similarly, the secondary
patency rates at 12 months ranged between 41% and 100%,
with a weighted mean of 71%, whereas the secondarypatency rates at 24 months ranged between 18% and 94%,
with a weighted mean of 60% (Table 2). The corresponding
weighted mean patency rates calculated separately for
upper-thigh prosthetic, mid-thigh prosthetic and trans-
posed femoral vein arteriovenous accesses are presented in
Table 2. It is evident that the 12-month patency rates of
femoral vein transposition arteriovenous fistulae are better
than those of both upper- and mid-thigh grafts, with
weighted mean primary patency rates of 83% versus 48%
and 43%, respectively, and weighted mean secondary
patency rates of 93% versus 69% and 67%, respectively.Specific adverse events complicating lower-
extremity vascular access
The most commonly encountered complications associated
with lower-extremity arteriovenous access were infection and
distal limb ischaemia secondary to steal syndrome (Table 1).
Other less frequently reportedcomplicationswereaneurysmal
dilatationepseudoaneurysm, venous hypertension, conges-
tive cardiac failure, lymphocoele and seroma formation.
The most feared complication, particularly associated
with prosthetic arteriovenous access construction in the
lower extremity, is infection. Because the reported
outcomes with regard to infection were conflicting, and in
an effort to enable meaningful comparisons between
studies, recommended standards for reports dealing with
arteriovenous haemodialysis access were used to grade
severity of infection.2 Therefore, all infections reported to
have been managed with non-operative means were clas-
sified as grade 1, whereas infections resulting in loss of the
arteriovenous access were classified as grade 2. Our anal-
ysis found that access loss as a result of infection tended to
be more common in upper-thigh and mid-thigh grafts than
femoral vein transposition arteriovenous access, which
reached statistical significance (18.40%, 18.33% versus
1.61%; P< 0.05) (Table 3). No difference between upper-
and mid-thigh arteriovenous grafts was found with regard
to infection (Table 3). Furthermore, when calculated for
the total number of prosthetic and autologous arteriove-
nous access, infection rates were higher in the former
group at a statistical significance (18.39% versus 1.61%,
P< 0.05) (Table 3). No limb loss (grade 3 infection) result-
ing from access-related infection has been reported.
Infection-related death has been reported by one study
only, reporting a rate of 4%.22
Steal syndrome resulting in limb ischaemia was also
a commonly described complication associated with lower-
extremity vascular access construction, especially in
elderly, diabetic patients with long-standing end-stage
renal disease. However, some studies failed to provide
adequate data regarding the severity of steal syndrome,
thus complicating the grading process. Ischaemic compli-
cations rates were found to be higher in femoral vein
transposition as compared with prosthetic arteriovenous
grafts (20.97% vs. 7.18%, P< 0.05) (Table 3), whereas no
statistically significant difference was found between
upper and mid-thigh prosthetic arteriovenous access (6.81%
vs. 10.00%, PZ 0.397) (Table 3). The amputation rate as
a result of lower-extremity arteriovenous access creation
ranged between 0% and 7% (Table 1).
Table 2 Weighted mean patency rates
Access
configuration
Upper thigh prosthetic
AV access
Mid-thigh prosthetic
AV access
Femoral vein
transposition
Total lower extremity AV access
Treatment time
(months)
12 24 12 24 12 24 12 24
Number of papers
(references)
4 (22, 23,
27, 32)
4 (22, 23,
27, 32)
2 (21, 26) 2 (21, 26) 3 (23, 24, 28) 9 (21, 22, 23,
24, 25, 26, 27,
28, 32)
7 (21, 22, 23, 24,
26, 27, 32)
Number of
accesses
251 251 60 60 62 373 333
PP 48 37 43 18 83 e 53 37
Number of papers
(references)
8 (20, 22,
25, 27,
29, 30,
31, 33)
8 (20, 22,
25, 27,
30, 31,
33, 34)
2 (21, 26) 2 (21, 26) 3 (23, 24, 28) 12 (20, 21, 22,
24, 25, 26, 27,
28, 29, 30, 31, 33)
11 (20, 21, 22, 24,
25, 26, 27, 30, 31,
33, 34)
Number of
accesses
576 464 60 60 47 683 546
SP 69 61 67 37 93 e 71 60
PP, primary patency; SP, secondary patency.
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A steady increase in the number and age of patients
undergoing chronic haemodialysis has emphasised the need
to evaluate potential alternate access sites to maintain
long-term vascular access. The lower extremity is increas-
ingly used as an access site in end-stage renal disease
patients. However, reports on several types of lower-
extremity arteriovenous access present conflicting results,
thus creating confusion regarding the indications, feasi-
bility and outcomes. Our attempt was to perform an anal-
ysis of the available literature in order to shed light onto
these aspects of lower-extremity vascular access.
The search of the pertinent literature often detected
retrospective case series, with only one prospective
comparative study of lower versus upper extremity and
another one of upper-thigh prosthetic versus femoral vein
transposition arteriovenous access having beenTable 3 Complication rates in prosthetic arteriovenous access
Upper thigh prosthetic AV access Mid-thigh
Infectiona 99/538 (18.40%) 11/60 (18
Steal 31/455 (6.81%) 6/60 (10.0
Upper thigh prosthetic AV access Femoral v
Infectiona 99/538 (18.40%) 1/62 (1.61
Steal 31/455 (6.81%) 13/62 (20
Mid-thigh prosthetic AV access Femoral v
Infectiona 11/60 (18.33%) 1/62 (1.61
Steal 6/60 (10.00%) 13/62 (20
Prosthetic Autologou
Infectiona 110/598 (18.39%) 1/62 (1.61
Steal 37/515 (7.18%) 13/62 (20
a Grade 2 infection.identified.25,23 No randomised controlled trials exist
comparing various types of lower-extremity arteriovenous
access or upper- and lower-extremity arteriovenous access.
The latter undertaking might possibly be performed only in
selected groups of end-stage renal disease patients. The
majority of the authors of the reviewed papers converge on
the fact that vascular access in the lower extremities
should only be attempted in selected patients, when all
other access sites in the upper extremities have been
exhausted, there is severe pathology in the central vein
trunks, and, possibly, in patients who are not suitable
candidates for peritoneal dialysis. Nevertheless, some
authors used patient’s preference as one of the criteria for
lower-extremity arteriovenous access construction, since it
allows two-handed self-cannulation, leaves both hands free
during dialysis and provides a better cosmetic appearance,
especially for young women with the dialysis site hidden
under their skirts.31,33prosthetic AV access P value OR (95% CI)
.33%) 0.990 0.995 (0.500e1.983)
0%) 0.397 1.484 (0.592e3.720)
ein transposition P value OR (95% CI)
%) 0.001 0.073 (0.010e0.531)
.97%) 0.000 3.543 (1.738e7.222)
ein transposition P value OR (95% CI)
%) 0.002 0.073 (0.009e0.585)
.97%) 0.095 2.388 (0.842e6.767)
s P value OR (95% CI)
%) 0.001 0.073 (0.010e0.530)
.97%) 0.000 3.427 (1.707e6.881)
370 G.A. Antoniou et al.Our analysis has found that autologous femoral vein
transposition arteriovenous fistula has better primary and
secondary patencies as compared with upper- and mid-
thigh prosthetic arteriovenous accesses. This finding
consolidates the results of the only existing prospective
study comparing upper-thigh prosthetic and femoral vein
transposition arteriovenous fistula in a non-randomised
fashion.23 Furthermore, from the existing literature, it
appears that the outcomes of lower-extremity arteriovenous
access are not significantly inferior to upper-extremity
vascular access, with femoral vein transposition presenting
comparable or even better results in terms of patency.25,35,36
Besides, one should take into consideration that the dialysis
population of the studies reporting on lower-extremity
vascular access is possibly different than upper-extremity
dialysis patients, with the former being on longer-term
haemodialysis with exhausted upper-extremity access
sites, of older age and, possibly, with more co-morbidities.
However, to draw definite conclusions, further comparative
studies with larger numbers of accesses and longer follow-
up are required.
The most prohibitive reported shortcomings associated
with lower-extremity vascular access are infection and
ischaemic complications. The main concern of placing
a prosthetic material for vascular access in proximity to the
groin is reported by most authors. In an attempt to avoid
placement of a prosthetic material in the potentially
contaminated area of the groin and preserve proximal
femoral vessels for later use, the upper-thigh loop tech-
nique was further modified by placing the graft along
a subcutaneous loop channel over the anterior mid-thigh
region, increasing the distance to the groin and the
urogenital area.14,21,26 However, our analysis revealed no
difference in infection rates between the upper- and the
mid-thigh groups of arteriovenous access. Several authors
have also proposed the autologous transposed superficial
femoral vein transposition in order to avoid infectious
complications associated with prosthetic access.11e13 In the
present analysis, infection tended to be more common in
upper-, mid-thigh and the overall prosthetic than autolo-
gous lower-extremity arteriovenous access. In addition,
several preventive measures have been proposed to keep
infection rates at low levels, including perioperative
prophylactic antibiotics and meticulous attention to aseptic
technique at the time of cannulation.30,31,37
Lower limb ischaemia resulting from access-related
arterial steal is another dreaded complication, particularly
likely to occur in diabetic patients with generalised arterial
occlusive disease. It seems that the advantage of autolo-
gous lower-extremity arteriovenous access in terms of
infection is offset by the high ischaemic complication rates
compared with prosthetic arteriovenous grafts. The repor-
ted incidence of ischaemic complications resulting from
lower-extremity vascular access construction seems to be
higher than the reported rates in the upper-extremity
proximal arteriovenous accesses.38,39 It has been suggested
that preoperative screening for peripheral arterial disease
with a detailed clinical evaluation and duplex ultrasound
scanning and/or arteriography, when required, be per-
formed in all patients scheduled for lower-extremity
vascular access construction.25,28,30 Gradman et al. in their
initial report had a high incidence of ischaemic limbcomplications, whereas after carefully selecting patients
and selectively performing femoral vein tapering, the
incidence of this complication declined.24 It seems that in
non-diabetic young patients without evidence of peripheral
arterial disease, the femoral vein transposition arteriove-
nous fistula should be possibly preferred. Management of
steal syndrome resulting in distal lower limb ischaemia
consisted of either closure ligation of the access or arterial
reconstruction and amputation. Venous hypertension is
a less frequently described complication, usually resulting
from previous undetected venous outflow obstruction,
which may be managed with endovenous means.40
There is limited evidence in the literature with regard to
the saphenous vein loop on the thigh as an alternative lower-
extremity arteriovenous access.16e19 These studies are
limited by the small numbers of accesses, which excluded
them from the present analysis. All of these studies report
dismal results, especially in terms of complication rates. The
most recent study documented a functional fistula for hae-
modialysis in 71.4% (five out of seven accesses constructed).
Furthermore, all patients developed stenoses in the loop of
the arteriovenous fistula, treated with either angioplasty or
open surgery. An earliest report with a larger series of
patients demonstrated that the saphenous vein loop to the
femoral artery arteriovenous fistula had worse primary
patency rates and a higher pseudoaneurysm rate than fore-
arm fistulae.41 It seems that the use of the saphenous vein
loop arteriovenous fistula in the thigh is not a satisfactory
solution for long-term haemodialysis.
In the interpretation of the results of the present anal-
ysis, one should take into consideration that relatively low
numbers of mid-thigh prosthetic and femoral vein trans-
position arteriovenous access as compared to upper-thigh
prosthetic vascular access were included in the analysis.
Our literature search identified two studies only reporting
on the mid-thigh prosthetic loop grafts fulfilling our selec-
tion criteria, and another three studies reporting on
autologous femoral vein transposition. Furthermore, these
reports come from centres having a special interest in these
difficult-access patients, which means that their results
may not be applicable to all units. Referral of such difficult
vascular access haemodialysis patients to specialist centres
might be required to achieve comparable results and
provide patients with the best possible care.Conclusions
Lower-extremity vascular access is increasingly used as an
alternative access site in patients unsuitable for upper-
extremity arteriovenous access creation. Our review has
shown that it has acceptable results in terms of patency,
with femoral vein transposition having better patency rates
than femoral grafts. Autologous access was also found to be
associated with less infective complications compared with
prosthetic arteriovenous access, however, at the expense of
increased ischaemic complications rates. It seems that the
type of lower-extremity vascular access should be chosen,
taking into account the patient’s co-morbidities, such as
peripheral arterial disease, and their immunological status.
However, because of the retrospective nature of most of the
studies included in this systematic review and the great
Lower Extremity Vascular Access 371variability in the reporting outcomes, our results should be
approached with caution. Further research with randomised
controlled trials is required to consolidate our results.
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